Drug Approval | December 07, 2023
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor
This product will be manufactured at Lupin’s Pithampur facility in India
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Icosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels
Canagliflozin and Metformin Hydrochloride Tablets had annual sales of US $49.4 million in the United States
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Subscribe To Our Newsletter & Stay Updated
